Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) FCF Margin (2016 - 2025)

Angiodynamics (ANGO) has disclosed FCF Margin for 16 consecutive years, with 5.45% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin rose 365.0% year-over-year to 5.45%, compared with a TTM value of 2.84% through Nov 2025, up 656.0%, and an annual FY2025 reading of 4.99%, up 510.0% over the prior year.
  • FCF Margin was 5.45% for Q4 2025 at Angiodynamics, up from 22.1% in the prior quarter.
  • Across five years, FCF Margin topped out at 22.72% in Q2 2025 and bottomed at 33.89% in Q3 2023.
  • Average FCF Margin over 5 years is 4.09%, with a median of 1.33% recorded in 2023.
  • The sharpest move saw FCF Margin skyrocketed 4078bps in 2021, then tumbled -1929bps in 2022.
  • Year by year, FCF Margin stood at 0.99% in 2021, then skyrocketed by 833bps to 7.28% in 2022, then fell by -19bps to 5.93% in 2023, then plummeted by -70bps to 1.8% in 2024, then soared by 203bps to 5.45% in 2025.
  • Business Quant data shows FCF Margin for ANGO at 5.45% in Q4 2025, 22.1% in Q3 2025, and 22.72% in Q2 2025.